MedAI Verdict
AI medical scribes

AI Medical Scribe

DeepScribe

by DeepScribe Inc.  ·  founded 2017  ·  US

Last verified

Ambient AI scribe made for oncology, with pre-charting and coding support.

At a glance

Pricing
Contact for pricing
HIPAA
Attested
SOC 2
Type II
EHRs
—
Founded
2017
HQ
US
On this page

Independent score  ·  By our public rubric

31/100Competitive
How it’s computed →
  • Regulatory & Compliance
    13/25

    HIPAA + (SOC2 or BAA) attested

  • Clinical Integration
    0/38.2

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    14.4/18

    Mid-tier funding and adoption

  • Sentiment & Transparency
    5.4/14

    Sentiment 60/100 across 5 mentions

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/12

    No FDA clearance listed

  • HIPAA / SOC2 / BAA13/13

    HIPAA + (SOC2 or BAA) attested

Clinical Integration

  • EHR integrations (count)0/21

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/12

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal8/12

    Mid-tier funding and adoption

  • Years in market6/6

    Founded 2017 (9 years)

Sentiment & Transparency

  • Clinician sentiment (Reddit)5/9

    Sentiment 60/100 across 5 mentions

  • Pricing transparency0/5

    No public pricing

Scored October 15, 2026 · Public scoring method v1.1.0

Bottom line

Ambient AI scribe made for oncology, with pre-charting and coding support.

Contact for pricing. HIPAA + SOC 2 Type II attested.

Editorial review  ·  By MedAI Verdict

Bottom line

DeepScribe is an ambient AI scribe built for oncology practices. It also offers pre-visit chart summaries and coding suggestions, and it works inside the oncology EHRs OncoEMR and iKnowMed. It publishes no price, and outside estimates run about $350 to $500 per provider per month. There are no peer-reviewed studies and almost no first-hand clinician reports. A community oncology group on OncoEMR or iKnowMed is the natural customer. A solo primary care physician who wants a self-serve scribe with a public price will find a better match elsewhere.

Pricing

DeepScribe pricing in 2026: what it actually costs

DeepScribe publishes no price: its pricing page returned no pricing content, and the homepage offers a demo request (as of October 2026). Third parties estimate about $350 to $500 per provider per month on annual contracts, up to $750 with EHR integration, plus setup. There is no self-serve plan or public trial.

What is not in the DeepScribe list price?

deepscribe.ai/pricing returned only a cookie banner, a September 2026 third-party check also found it not available, and the homepage offers a demo request. There is no self-serve plan and no public trial.

Third parties supply estimates, and some of them are competitors. About $350 to $500 per provider per month on annual contracts, with EHR-integrated tiers (Epic, athenahealth) at about $450 to $500 or more and up to $750. Freed's blog says most providers pay $350 to $750 a month, quote required. One directory puts a solo provider at $200 to $400, 10 providers at about $2,500 a month and 100 users at about $20,000 a month, with up to 20% off for annual payment. One-time setup is estimated at $500 to $1,000 per provider for small practices and $1,000 to $5,000 elsewhere.

A third party reports a KLAS score of 98.8 out of 100, and we found no KLAS price. The best labelled estimate is about $350 to $500 per provider per month plus setup. Refund terms are not public.

Is DeepScribe worth it?

It fits a specialty practice, such as oncology, cardiology, GI or neurology (the vendor's list), that wants a template-tuned scribe and will work through a sales process. It fits less well for a clinician who needs a listed price, where DeepCura and Freed publish theirs. The specialty template list is worth requesting with the quote.

Verified October 14, 2026 from deepscribe.ai.

What is DeepScribe and who sells it?

DeepScribe's homepage calls it "the ambient AI made for oncology" (DeepScribe website, October 2026). The product includes an AI medical scribe, SmartPrep pre-charting that surfaces relevant patient data before each visit, AI coding for E/M, ICD-10 and HCC, and a Customization Studio. Cardiology, gastroenterology, neurology, orthopedics and urology are also listed as specialties.

DeepScribe Inc. was founded in San Francisco in June 2017 by Akilesh Bapu, Kairui Zeng and Matthew Ko (Crunchbase). Index Ventures led a $30M Series A in January 2022 (Business Wire). A Series B of about $24M followed in October 2023, but reports name different investors, and total funding is reported between $37M and $64M.

What does it do well?

Oncology is the clear focus. DeepScribe says it is used across 90% of community oncology centers, though the denominator for that figure is unclear. One testimonial on its site says "90-95% of the time, I'm not making any adjustments to the note", and another says note time fell from 7 to 10 minutes to 1 to 2 minutes. Both are vendor-selected. The homepage shows a KLAS 2025 Spotlight Report score of 98.8 out of 100, which DeepScribe displays itself. The vendor also says users average under one correction per note after 20 days.

The EHR coverage fits the specialty. OncoEMR and iKnowMed are accessed from inside the product, the homepage links an Epic integration page, and a pricing source mentions an athenahealth tier.

What do critics and users say?

Most complaints come from competitors' pages. DeepCura's and Vero's reviews quote Software Advice excerpts that mention inconsistent accuracy with terminology or accents, incomplete notes that needed reprocessing, notes arriving hours later and no Android app (DeepCura). Those reviews also describe the service as AI with human backup, which the homepage text does not state.

Five Reddit posts mention DeepScribe, and one describes using it. In 2022 a r/FamilyMedicine poster asked about cost and said the sales rep was "super cagey". In 2023 a r/Psychiatry poster wrote that the technology was "pie in the sky" and "Dragon is the only one sufficient". Both predate the current product.

Is it compliant?

The homepage shows SOC 2 and HIPAA badges that link to a trust center, without a report type or date. HITRUST and a BAA are not stated. DeepScribe is a documentation tool.

How much does DeepScribe cost?

A quote is required, there is no self-serve plan and no public trial. Outside estimates, some from competitors, run about $350 to $500 per provider per month on annual contracts, plus a one-time setup fee of $500 to $5,000 (DeepCura, Clunic, scribing.io).

How does it compare?

Abridge, Ambience, Suki, DAX Copilot, Nabla, Augmedix, Freed, Heidi, Dragon Medical One and Epic AI Charting compete in ambient scribing. Freed and DeepCura publish "DeepScribe alternatives" pages, so they are interested parties. DeepScribe's differentiator is oncology workflow and OncoEMR access.

The verdict

An oncology group on OncoEMR or iKnowMed should book the demo and ask for the contract price in writing, whether human review is still part of the service and the date of the SOC 2 report. Everyone else, from a solo physician to a practice that wants a free trial first, should start with a scribe that publishes its price.

Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Compliance + integration

What deploys cleanly

Carries HIPAA, SOC2 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

Vendor stability

Who builds it

DeepScribe (DeepScribe Inc.) was founded in 2017 in US, putting it 9 years into market.

Clinician sentiment

What clinicians say about DeepScribe

Aggregated from 5 public clinician mentions. We quote with attribution under fair-use commentary.

What clinicians say

Aggregated sentiment from 5 public mentions

Overall
leaning positive
Positive share
60%
Score
0.14
Sources
Reddit·5

Themes mentioned

  • pricing2

Pros most mentioned

  • 01amazing potential
  • 02ai with human backup
  • 03promising pre-charting solution

Cons most mentioned

  • 01pricing transparency issues
  • 02tech not there yet
  • 03not worth paying for

Direct quotes

“Deepscribe? Has anyone used this company for AI scribe services? How well does it work? And most importantly, how much does it cost?? The spokesperson I've been emailing is being super cagey about it.”
Redditr/FamilyMedicineMay 2022-0.20View source
“Deepscribe is the pie in the sky dream but their tech isnt there yet to be worth paying for. Dragon is the only one sufficient.”
Redditr/PsychiatryFeb 2023-0.70View source
“Has anyone used Ai Pre-charting solutions? The folks at deepscribe have been pushing a new pre-charting solution to our practice for chart summaries and stuff. Currently we do all our chart prep manually (myself and my MA). This is looking quite promising. Wanted to learn from the folks here if anyone has tried any of these AI pre-charting tools and what their experience has be…”
Redditr/FamilyMedicineNov 2025+0.40View source

Summarized from 5 public clinician mentions. We quote with attribution under fair-use commentary and never republish full reviews. See our editorial methodology for source weights.

Frequently asked

Common questions about DeepScribe

Answers below cover the most-searched clinician questions for DeepScribe in 2026. Updated as vendor docs and pricing change.